Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

Por Ziemssen, Tjalf, Thomas, Katja
Publicado no Ther Adv Neurol Disord (2017)

Multiple sclerosis: clinical profiling and data collection as prerequisite for personalized medicine approach

Por Ziemssen, Tjalf, Kern, Raimar, Thomas, Katja
Publicado no BMC Neurol (2016)

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease

Por Thomas, Katja, Schrötter, Hagen, Halank, Michael, Ziemssen, Tjalf
Publicado em 2014

Use and Acceptance of Electronic Communication by Patients With Multiple Sclerosis: A Multicenter Questionnaire Study

Por Haase, Rocco, Schultheiss, Thorsten, Kempcke, Raimar, Thomas, Katja, Ziemssen, Tjalf
Publicado em 2012

Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System

Por Kern, Raimar, Haase, Rocco, Eisele, Judith Christina, Thomas, Katja, Ziemssen, Tjalf
Publicado no Interact J Med Res (2016)

Cortisol Awakening Response Is Linked to Disease Course and Progression in Multiple Sclerosis

Por Kern, Simone, Krause, Ivonne, Horntrich, Antje, Thomas, Katja, Aderhold, Julia, Ziemssen, Tjalf
Publicado em 2013

Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS

Por Thomas, Katja, Eisele, Judith, Rodriguez-Leal, Francisco Alejandro, Hainke, Undine, Ziemssen, Tjalf
Publicado no Neurol Neuroimmunol Neuroinflamm (2016)

Rationale, design, and methods of a non-interventional study to establish safety, effectiveness, quality of life, cognition, health-related and work capacity data on Alemtuzumab in...

Por Ziemssen, Tjalf, Engelmann, Ulrich, Jahn, Sigbert, Leptich, Alexandra, Kern, Raimar, Hassoun, Lina, Thomas, Katja
Publicado no BMC Neurol (2016)

Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation

Por Thomas, Katja, Sehr, Tony, Proschmann, Undine, Rodriguez-Leal, Francisco Alejandro, Haase, Rocco, Ziemssen, Tjalf
Publicado no J Neuroinflammation (2017)

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis

Por Thomas, Katja, Dietze, Kristin, Wehner, Rebekka, Metz, Imke, Tumani, Hayrettin, Schultheiß, Thorsten, Günther, Claudia, Schäkel, Knut, Reichmann, Heinz, Brück, Wolfgang, Schmitz, Marc, Ziemssen, Tjalf
Publicado em 2014

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS

Por Ziemssen, Tjalf, Tumani, Hayrettin, Sehr, Tony, Thomas, Katja, Paul, Friedemann, Richter, Nils, Samara, Emil, Spiegelstein, Ofer, Sorani, Ella, Bar-Ilan, Oren, Mimrod, Dorit, Hayardeny, Liat
Publicado no J Neuroinflammation (2017)